Philly Jury Set To Deliberate In Xarelto Injury Case
A Philadelphia jury was urged during closing arguments on Friday to find that inadequate warnings from a pair of Johnson & Johnson and Bayer AG units for the blood-thinner Xarelto left...To view the full article, register now.
Already a subscriber? Click here to view full article